AN2 Therapeutics (ANTX) Net Equity Issued and Repurchased (2021 - 2026)
AN2 Therapeutics' Net Equity Issued and Repurchased came in at $39,000 for Q2 2026, unchanged from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AN2 Therapeutics reported Net Equity Issued and Repurchased of $126,000, up 231.6% year-over-year; for FY2025, it came in at $86,000, down 61.8% from FY2024.
- Net Equity Issued and Repurchased has declined in each of the last three years, though with a four-year compound annual growth rate of 67.2% (FY2021 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $225,000 in FY2024 (-38.5%), $366,000 in FY2023 (-99.5%), $70.37 million in FY2022 and $11,000 in FY2021.
- The five-year range for quarterly Net Equity Issued and Repurchased is -$10,000 (Q3 2022) to $63.2 million (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | AN2 Therapeutics | 164.30 Mn | -121.79 Mn | - | 237,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 237,000.00 |
| Jun 30, 2026 | 54,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 349,000.00 |
| Sep 30, 2023 | 266,000.00 |
| Jun 30, 2023 | 19.05 Mn |
| Mar 31, 2023 | 199,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Jun 30, 2022 | 7.18 Mn |
| Mar 31, 2022 | 63.19 Mn |
| Dec 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 79.74 Mn |
API Access
AN2 Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();